Pfizer's first-in-class JAK inhibitor pricey for rheumatoid arthritis market (Q44214968)
Jump to navigation
Jump to search
scientific article published in January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pfizer's first-in-class JAK inhibitor pricey for rheumatoid arthritis market |
scientific article published in January 2013 |
Statements
1 reference
Pfizer's first-in-class JAK inhibitor pricey for rheumatoid arthritis market (English)
1 reference
Ken Garber
1 reference
1 January 2013
1 reference
1 reference
1 reference
Identifiers
1 reference